Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_assertion type Assertion NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_head.
- NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_assertion description "[Cyclin D1 overexpression was seen in hyperplasia and metaplasia (6%), mild dysplasia (17%), moderate dysplasia (46%), and CIS (38%) in patients with cancer but was lost in 5% of the patients during the process of invasion; it was also observed in patients with no cancer progression (14%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_provenance.
- NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_assertion evidence source_evidence_literature NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_provenance.
- NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_assertion SIO_000772 10037171 NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_provenance.
- NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_assertion wasDerivedFrom befree-2016 NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_provenance.
- NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_assertion wasGeneratedBy ECO_0000203 NP246450.RAQpm27e2HsBzjiHO6GhmeSbefynWUlayLjJQer7I3_lQ130_provenance.